Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Assessing the risk of prostate cancer in patients with borderline or moderately increased total PSA (4.0-10.0 ng/mL)
Determining which patients should have follow-up prostate biopsy
In individuals with a total PSA between 4.0 and 10.0 ng/mL, free:total PSA ratio could help determine the relative risk of prostate cancer. The lower the free:total PSA ratio, the higher the risk of prostate cancer.
Electrochemiluminescent Immunoassay (ECLIA)